Report on Form 10-Q and other documents filed by Kredivo or VIH from time to time with the U.S. Securities and Exchange
Commission (the SEC). These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. In addition,
there may be additional risks that neither VIH nor FinAccel presently know, or that VIH or FinAccel currently believe are immaterial, that could also cause actual results to differ from those contained in the forward-looking statements.
Forward-looking statements reflect VIHs and FinAccels expectations, plans, projections or forecasts of future events and view. If any of the risks materialize or VIHs or FinAccels assumptions prove incorrect, actual results
could differ materially from the results implied by these forward-looking statements.
Forward-looking statements speak only as of the date they are made.
VIH and FinAccel anticipate that subsequent events and developments may cause their assessments to change. However, while Kredivo, VIH and FinAccel may elect to update these forward-looking statements at some point in the future, Kredivo, VIH and
FinAccel specifically disclaim any obligation to do so, except as required by law. The inclusion of any statement in this document does not constitute an admission by FinAccel nor VIH or any other person that the events or circumstances described in
such statement are material. These forward-looking statements should not be relied upon as representing VIHs or FinAccels assessments as of any date subsequent to the date of this document. Accordingly, undue reliance should not be
placed upon the forward-looking statements. In addition, the analyses of FinAccel and VIH contained herein are not, and do not purport to be, appraisals of the securities, assets or business of the FinAccel, VIH or any other entity.
Non-IFRS Financial Measures
This document may also include
references to non-IFRS financial measures. Such non-IFRS measures should be considered only as supplemental to, and not as
superior to, financial measures prepared in accordance with IFRS, and such non-IFRS measures may
be different from non-IFRS financial measures used by other companies.
Important
Information About the Proposed Transactions and Where to Find It
This document relates to a proposed transaction between FinAccel and VIH. This
document does not constitute an offer to sell or exchange, or the solicitation of an offer to buy or exchange, any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, sale or exchange would be unlawful
prior to registration or qualification under the securities laws of any such jurisdiction. The proposed transactions will be submitted to shareholders of VIH for their consideration.
Kredivo intends to file a registration statement on Form F-4 (the Registration
Statement) with the SEC which will include preliminary and definitive proxy statements to be distributed to VIHs shareholders in connection with VIHs solicitation for proxies for the vote by VIHs shareholders in connection
with the proposed transactions and other matters as described in the Registration Statement, as well as the prospectus relating to the offer of the securities to be issued to FinAccels shareholders in connection with the completion of the
proposed business combination. VIH and Kredivo also will file other documents regarding the proposed transaction with the SEC.
After the Registration
Statement has been filed and declared effective, VIH will mail a definitive proxy statement and other relevant documents to its shareholders as of the record date established for voting on the proposed transactions. This communication is not a
substitute for the Registration Statement, the definitive proxy statement/prospectus or any other document that VIH will send to its shareholders in connection with the business combination. VIHs shareholders and other interested persons are
advised to read, once available, the preliminary proxy statement/prospectus and any amendments thereto and, once available, the definitive proxy statement/prospectus, in connection with VIHs solicitation of proxies for its special meeting of
shareholders to be held to approve, among other things, the proposed transactions, because these documents will contain important information about VIH, Kredivo, FinAccel and the proposed transactions. Shareholders and investors may also obtain a
copy of the preliminary or definitive proxy statement, once available, as well as other documents filed with the SEC regarding the proposed transactions and other documents filed with the SEC by VIH, without charge, at the SECs website located
at www.sec.gov or by directing a request to VIH. The information contained on, or that may be accessed through, the websites referenced in this document is not incorporated by reference into, and is not a part of, this document.